Diabetic Foot Ulcer (DFU) Treatment Market accrued earnings worth approximately 4.10 (USD Billion) in 2019 and is set to record a CAGR of more than 8.1% over the period from 2020 to 2026.
Diabetic Foot Ulcer (DFU) Treatment Market
The global Diabetic Foot Ulcer (DFU) Treatment market accrued earnings worth approximately 4.10 (USD Billion) in 2019 and is set to record a CAGR of more than 8.1% over the period from 2020 to 2026. The report offers assessment and analysis of the Diabetic Foot Ulcer (DFU) Treatment market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).
Diabetic foot ulcers occur most prominently in the patients suffering from diabetes mellitus that is not controlled in the proper manner. Moreover, it is a result of poor glycemic control, dry skin, ischemia, peripheral vascular disorder, Osteomyelitis, calluses, poor foot care, foot infection, and underlying neuropathy. Furthermore, it causes foot osteomyelitis and can lead to amputating of lower limbs. Patients having diabetes mellitus develop severe atherosclerosis of blood vessels in foot as well as in legs and this causes diabetic foot ulcers in the subjects.
Additionally, these foot ulcers are found in the areas of foot that are exposed to continuous trauma as well as pressure sensations. According to NCBI, nearly five percent of diabetes mellitus patients suffer from foot ulcers. As per NIH researchers, diabetic foot ulcers are the most common ones and nearly more than eighty percent of amputations of foot are caused due to these ulcers. For the record, in developing countries like India large number of people affected due to diabetic foot ulcers have to undergo leg amputation each year. The factors responsible being barefoot walking, lack of knowhow about diabetic foot ulcers, and late patient representation in hospitals as well as financial hitches.
Moreover, several treatment options are available for treating diabetic foot ulcers including surgical debridement, blood sugar control, wound off-loading, glycemic control, vascular assessment, infection, and dressings facilitating moist wound environment. Other adjunct type of treatments used for quick healing of diabetic foot ulcers include hyperbaric oxygen treatment, systemic therapy, electrical stimulation, bio-engineered skin, negative pressure wound therapy, and use of non-surgical wound debridement agents. The latter ones have proved to be beneficial in healing the wounds caused due to foot ulcers to a large extent.
Rise in the aging population prone to chronic ailments like diabetes will open new vistas of growth for the diabetic foot ulcer (DFU) treatment industry over the years to come. Apparently, high global occurrence of diabetic mellitus and acceptance of new wound care equipment for treating these foot ulcers will drive the market trends. In addition to this, escalating awareness pertaining to myriad treatment alternatives for diabetic foot ulcers will drive the business growth over the forecast timespan.
Furthermore, surge in the healthcare spending and huge investments for developing new & advanced treatment methods will exponentiate the market growth rate within the next couple of years. Nonetheless, poor healthcare infrastructure facility available in underdeveloped as well as emerging economies and huge costs of diabetic foot ulcer management will decimate the market growth over the forecast timeline. However, launching of new therapeutics methods for treating the disease along with enhanced biologics and constant focus on research activities to avoid limb amputations will offset the adverse impact of the hindrances on the market growth over 2020-2026.
The growth of the market in the sub-continent over the estimated timespan is due to increase in the number of diabetics among the U.S. patient population. As per NCBI, high cases of foot ulcers witnessed in Latinos, Native Americans, and African Americans in the U.S. will further drive the regional market trends.
Key players influencing the market growth are Medtronic Plc.; Medline Industries, Inc., B. Braun Melsungen AG; Acelity L.P. Inc.; ConvaTec, Inc.; Smith & Nephew Plc.; Organogenesis; Coloplast A/S; 3M Healthcare; Molnlycke Health Care AB; Inc.; and BSN Medical GMBH.
By Treatment Type
By Ulcer Type
Rise in the aging population prone to chronic ailments like diabetes will open new vistas of growth for the diabetic foot ulcer (DFU) treatment industry over the years to come.
The CAGR of the industry is expected to be over 8.1% during the forecast timeline.
North American region will contribute lucratively towards the global market value over the estimated timeline.
The key market participants include Medtronic Plc.; Acelity L.P. Inc.; ConvaTec, Inc.; Organogenesis; Coloplast A/S; 3M Healthcare; B. Braun Melsungen AG; Smith & Nephew Plc.; Molnlycke Health Care AB; Inc.; Medline Industries, Inc.; and BSN Medical GMBH.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed